Stereotactic Radiosurgery in Treating Patients With Brain Tumors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00019578|
Recruitment Status : Completed
First Posted : March 2, 2007
Last Update Posted : March 23, 2012
|Condition or disease||Intervention/treatment||Phase|
|Adult Central Nervous System Germ Cell Tumor Adult Malignant Meningioma Adult Medulloblastoma Adult Noninfiltrating Astrocytoma Adult Oligodendroglioma Adult Craniopharyngioma Adult Meningioma Brain Metastases Adult Ependymoma Adult Pineal Parenchymal Tumor Adult Brain Stem Glioma Adult Infiltrating Astrocytoma Mixed Gliomas Stage IV Peripheral Primitive Neuroectodermal Tumor||Procedure: Sterotactic radiosurgery||Phase 1|
OBJECTIVES: I. Establish stereotaxic radiosurgery as a treatment technique at the National Institute of Health in patients with intracranial neoplasms.
II. Assess the response rate, local control, time to progression, pattern of failure, and magnetic resonance spectrographic data following this therapy in these patients.
PROTOCOL OUTLINE: All patients undergo stereotaxic head frame placement, followed by stereotaxic radiosurgery on day 1. The dosage of radiation therapy administered is dependent on the tumor diameter.
Patients are followed at 2 and 6 weeks and then every 3 months for 5 years.
Up to 30 patients will be accrued for this study within 7-10 months.
|Study Type :||Interventional (Clinical Trial)|
|Official Title:||Phase I Pilot Study of Stereotaxic Radiosurgery in Patients With Intracranial Neoplasms|
|Study Start Date :||November 1998|
|Study Completion Date :||May 2002|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00019578
|United States, Maryland|
|Radiation Oncology Branch|
|Bethesda, Maryland, United States, 20892|
|Study Chair:||Brian G. Fuller||National Cancer Institute (NCI)|